
Medical Device and Pharmaceutical R&D Manufacturer
WEGO Shares(01066) announced that the board of directors was informed by the company's controlling shareholder, Weigao Group, that based on the recognition of the company’s long-term investment value, as well as confidence in the prospects of China’s economic growth and the medical device industry, on May 13, 2026, and May 14, 2026, Weigao Group purchased a total of 3,552,800 H shares of the company on the open market using its own funds. These purchases represent approximately 0.08% of the total number of issued H shares and the total issued share capital of the company, respectively.
Immediately following this increase in holdings, as of the date of this announcement, WEGO Group collectively holds 2.103 billion H shares of the company, accounting for approximately 46.51% of the total issued H shares and 46.02% of the company's total issued share capital. According to WEGO Group, it has full confidence in the future development prospects of the group and does not rule out the possibility of considering further increasing its shareholding in the company at an appropriate time, subject to applicable laws and regulations.